Extendicare (TSE:EXE) Stock Gets Price Target Trim from National Bank Financial

Key Points

• National Bank Financial cut Extendicare’s price target from C$45 to C$40 while maintaining an “outperform” rating, implying approximately 46.95% upside from the prior close.
• Analyst sentiment remains positive: seven analysts rate the stock Buy, with a consensus rating of “Buy” and an average price target of C$37.00.
• Extendicare shares fell C$0.26 to C$27.22 during Wednesday trading. The company recently reported C$0.38 in quarterly EPS on C$611.04 million in revenue.

Extendicare (TSE:EXE - Get Free Report) had its price target decreased by stock analysts at National Bank Financial from C$45.00 to C$40.00 in a research note issued to investors on Wednesday, BayStreet reports. The firm presently has an "outperform" rating on the stock. National Bank Financial's target price indicates a potential upside of 46.95% from the stock's previous close.

A number of other equities research analysts have also commented on the stock. Canaccord Genuity Group increased their price objective on shares of Extendicare from C$37.00 to C$44.00 and gave the stock a "buy" rating in a report on Monday, August 10th. Royal Bank Of Canada raised their price objective on shares of Extendicare from C$38.00 to C$39.00 and gave the company an "outperform" rating in a research report on Friday, August 14th. Finally, Desjardins dropped their target price on shares of Extendicare from C$40.00 to C$39.00 and set a "buy" rating for the company in a research note on Monday, August 10th. Seven analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, Extendicare has a consensus rating of "Buy" and a consensus target price of C$37.00.

Extendicare Price Performance

Shares of EXE stock traded down C$0.26 during trading hours on Wednesday, hitting C$27.22. 261,802 shares of the company's stock were exchanged, compared to its average volume of 439,499. The stock's 50-day moving average is C$30.04 and its 200-day moving average is C$32.12. The company has a debt-to-equity ratio of 159.54, a current ratio of 0.75 and a quick ratio of 0.98. The stock has a market cap of C$2.59 billion, a price-to-earnings ratio of 20.84 and a beta of 1.39. Extendicare has a 52 week low of C$15.30 and a 52 week high of C$39.14.

Extendicare (TSE:EXE - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported C$0.38 earnings per share for the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%. The company had revenue of C$611.04 million during the quarter. As a group, research analysts forecast that Extendicare will post 0.61 EPS for the current year.

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors' population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.